On February 15, 2019, Magistrate Judge Cathy L. Waldor issued a text order denying defendants GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd.’s motion to stay the district court proceedings pending resolution of their Rule 23(f) petition to review the Court’s order certifying the direct purchaser class.
GSK and Teva petitioned the Third Circuit for an appeal of the class certification order in December 2018. In January, the drugmakers asked the district court to pause the case while their petition to the Third Circuit plays out, arguing that denying a stay would cause them “irreparable harm” because it will force them “to do substantial motion and pre-trial preparations” that they contend could be “unnecessary.” Plaintiffs opposed the motion, arguing that the drugmakers have failed to show any hardship from proceeding with the nearly 7-year-old case and that indefinitely delaying the case would prejudice the plaintiffs.
In her order denying defendants’ request to stay the district court proceedings, Judge Waldor ordered the parties to meet and propose a briefing schedule for motions in the case.
The Lamictal case is pending in federal court in New Jersey. The case is a pay-for-delay case involving GlaxoSmithKline’s blockbuster drug Lamictal, which treats epilepsy and bipolar disorder. The plaintiffs allege that in 2005 GSK paid Teva not to come to market with its generic version of Lamictal tablets until 2008. But instead of paying Teva in cash, GSK’s reverse payments to Teva included the promise that GSK would not launch an authorized generic version of Lamictal for 6 months after Teva entered the market with generic Lamictal.
Faruqi & Faruqi represents the direct purchaser plaintiffs in this litigation.
About Faruqi & Faruqi, LLP
Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour, personal injury and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in California, Delaware, Georgia and Pennsylvania.
Since its founding in 1995, Faruqi & Faruqi, LLP has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, direct purchasers, consumers and employees.
To schedule a free consultation with our attorneys and to learn more about your legal rights, call our offices today at (877) 247-4292 or (212) 983-9330.
About Kristyn Fields
Kristyn Fields' practice is focused on antitrust litigation. Kristyn is an Associate in the firm's New York office. Prior to joining F&F, Kristyn interned for the Honorable Martin Marcus, New York Supreme Court, Bronx County. As well, Kristyn participated in the Brooklyn Law Incubator & Policy Clinic providing pro bono counsel to emerging start-up companies. While at Brooklyn Law School, Kristyn served as an Executive Articles Editor of the Brooklyn Journal of Corporate, Financial & Commercial Law. Also, Kristyn was a member of the Moot Court Honor Society. Kristyn earned her J.D. from Brooklyn Law School (2016). Kristyn earned her undergraduate degree from Boston College (B.A., Political Science, 2013). Kristyn is licensed to practice law in New York.